Number of the records: 1  

PEGylated poly(lactic-co-glycolic acid) nanoparticles doped with molybdenum-iodide nanoclusters as a promising photodynamic therapy agent against ovarian cancer

  1. 1.
    SYSNO ASEP0573899
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitlePEGylated poly(lactic-co-glycolic acid) nanoparticles doped with molybdenum-iodide nanoclusters as a promising photodynamic therapy agent against ovarian cancer
    Author(s) Verger, A. (FR)
    Dollo, G. (FR)
    Brandhonneur, N. (FR)
    Martinais, S. (FR)
    Cordier, S. (FR)
    Lang, Kamil (UACH-T) SAI, RID, ORCID
    Amela-Cortes, M. (FR)
    Kirakci, Kaplan (UACH-T) SAI, RID, ORCID
    Source TitleMaterials Advances. - : Royal Society of Chemistry
    Roč. 4, č. 15 (2023), s. 3207-3214
    Number of pages8 s.
    Languageeng - English
    CountryGB - United Kingdom
    Keywordscluster complexes ; polymer
    Subject RIVCA - Inorganic Chemistry
    OECD categoryInorganic and nuclear chemistry
    R&D ProjectsGA21-11688S GA ČR - Czech Science Foundation (CSF)
    8J20FR008 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Method of publishingOpen access
    Institutional supportUACH-T - RVO:61388980
    UT WOS001023678700001
    EID SCOPUS85165306265
    DOI10.1039/d3ma00206c
    AnnotationPhotodynamic applications requires efficient intracellular uptake of the photosensitizer that can be achieved through the development of nanoscaled delivery system. Herein, we prepared PEGylated poly(lactic-co-glycolic acid) nanoparticles doped with an octahedral molybdenum cluster complex bearing iodine inner ligands and o-carborane carboxylate apical ligands. This complex is a potent red luminophore and singlet oxygen photosensitizer under UV/blue-light irradiation, making it an attractive theranostic tool for photodynamic therapy and emerging modalities such as X-ray-induced photodynamic therapy or boron neutron/proton capture therapy. However, its hydrophobicity hinders its use in biological application and requires its encapsulation in nanocarriers. The nanoparticles, prepared using the solvent displacement method, displayed ideal properties in terms of size and zeta potential as a drug delivery system and exhibited a robust colloidal stability in biological medium, without the need of additional surfactant. The encapsulated complexes conserved their efficient red luminescence and singlet oxygen photosensitizing activity, while being protected from the detrimental hydrolysis process generally observed for this type of complexes in aqueous media. Evaluation of the in vitro biological activity of the nanoparticles against the ovarian cancer cell line SKOV-3 evidenced efficient uptake into the cellular membrane and cytoplasm and intensive phototoxic effect associated with an appreciable therapeutic window, suggesting potential as a photodynamic therapy agent against ovarian cancer.
    WorkplaceInstitute of Inorganic Chemistry
    ContactJana Kroneislová, krone@iic.cas.cz, Tel.: 311 236 931
    Year of Publishing2024
    Electronic addresshttps://hdl.handle.net/11104/0344467
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.